Takagaki T - Search Results

1

Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.

Fujii H, Ajioka Y, Kazami S, Takagaki T, Gong Zhu X, Hirose S, Watanabe H, Shirai T. Fujii H, et al. Among authors: takagaki t. J Pathol. 2002 Jul;197(3):298-306. doi: 10.1002/path.1122. J Pathol. 2002. PMID: 12115875

2

Genetic progression and divergence in pancreatic carcinoma.

Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Yamano M, et al. Among authors: takagaki t. Am J Pathol. 2000 Jun;156(6):2123-33. doi: 10.1016/S0002-9440(10)65083-3. Am J Pathol. 2000. PMID: 10854233 Free PMC article.

3

Genetic classification of combined hepatocellular-cholangiocarcinoma.

Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T, Uekusa T, Takagaki T, Kadowaki N, Shirai T. Fujii H, et al. Among authors: takagaki t. Hum Pathol. 2000 Sep;31(9):1011-7. doi: 10.1053/hupa.2000.9782. Hum Pathol. 2000. PMID: 11014564

4

Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.

Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, Hirose S, Shirai T. Fujii H, et al. Among authors: takagaki t. Hum Pathol. 2002 Apr;33(4):421-8. doi: 10.1053/hupa.2002.124118. Hum Pathol. 2002. PMID: 12055677

5

Genetic evolution of alpha fetoprotein producing gastric cancer.

Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, Shimoda T. Fujii H, et al. Among authors: takagaki t. J Clin Pathol. 2003 Dec;56(12):942-9. doi: 10.1136/jcp.56.12.942. J Clin Pathol. 2003. PMID: 14645355 Free PMC article.

6

Frequent down-regulation of HIVEP2 in human breast cancer.

Fujii H, Gabrielson E, Takagaki T, Ohtsuji M, Ohtsuji N, Hino O. Fujii H, et al. Among authors: takagaki t. Breast Cancer Res Treat. 2005 May;91(2):103-12. doi: 10.1007/s10549-004-5779-6. Breast Cancer Res Treat. 2005. PMID: 15868437

7

Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.

Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T. Han B, et al. Among authors: takagaki t. FEBS Open Bio. 2020 Nov;10(11):2375-2387. doi: 10.1002/2211-5463.12985. Epub 2020 Oct 5. FEBS Open Bio. 2020. PMID: 32961616 Free PMC article.

8

Induction by rapamycin and proliferation‑promoting activity of Hspb1 in a Tsc2‑deficient cell line.

Kitano T, Nishikawa K, Takagaki T, Sugitani Y, Hino O, Kobayashi T. Kitano T, et al. Among authors: takagaki t. Exp Ther Med. 2023 May 12;26(1):315. doi: 10.3892/etm.2023.12014. eCollection 2023 Jul. Exp Ther Med. 2023. PMID: 37273756 Free PMC article.

9

Corrigendum: Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions.

Baldavira CM, Prieto TG, Machado-Rugolo J, de Miranda JT, da Silveira LKR, Velosa APP, Teodoro WR, Ab'Saber A, Takagaki T, Capelozzi VL. Baldavira CM, et al. Among authors: takagaki t. Front Oncol. 2025 Jan 9;14:1543813. doi: 10.3389/fonc.2024.1543813. eCollection 2024. Front Oncol. 2025. PMID: 39850818 Free PMC article.

10

Population pharmacokinetics of blonanserin in Japanese adolescent and adult patients with schizophrenia.

Nemoto D, Takagaki T, Kitamura A, Tomita Y. Nemoto D, et al. Among authors: takagaki t. Drug Metab Pharmacokinet. 2024 Nov 28;60:101043. doi: 10.1016/j.dmpk.2024.101043. Online ahead of print. Drug Metab Pharmacokinet. 2024. PMID: 39787632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters